川能動力(000155.SZ):擬按照持股比例為鼎盛鋰業提供不超3億元財務資助
格隆匯12月16日丨川能動力(000155.SZ)公佈,四川能投鼎盛鋰業有限公司(“鼎盛鋰業”)為公司持股25.5%的參股公司。為加快公司鋰電產業發展,便於公司統籌行使對上游鋰礦、下游鋰鹽項目公司的管理職能,四川省能源投資集團有限責任公司(“四川能投”)和四川能投資本控股有限公司(“川能資本”)將合計持有鼎盛鋰業25.5%股權委託公司管理。基於公司鋰電戰略佈局和產業協同發展,為進一步提升管理效率和經營效率,公司擬按照持股比例以自有資金為鼎盛鋰業提供不超過人民幣3億元的財務資助,公司控股股東四川能投及其關聯方川能資本將按其持股比例合計25.5%提供同等條件的財務資助。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.